Literature DB >> 4972373

A comparison of general drug utilization in a metropolitan community with utilization under a drug prepayment plan.

M R Greenlick, B J Darsky.   

Abstract

Mesh:

Year:  1968        PMID: 4972373      PMCID: PMC1229046          DOI: 10.2105/ajph.58.11.2121

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN: 0002-9572


× No keyword cloud information.
  2 in total

1.  Experience with a prepaid drug benefit.

Authors:  A W BREWSTER; S I ALLEN; L M KRAMER
Journal:  J Health Hum Behav       Date:  1963

2.  Impact of a reduced-charge drug benefit in a prepaid group practice plan.

Authors:  M R Greenlick; E W Saward
Journal:  Public Health Rep       Date:  1966-10       Impact factor: 2.792

  2 in total
  6 in total

Review 1.  Economic impact of cost-containment strategies in third party programmes in the US. Part II.

Authors:  C M Kozma; R M Schulz; W M Dickson; J T Dye; E R Cox; D A Holdford; L Michael; W N Yates; T L Young
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

2.  Practitioners and health policy. Case of the Ontario Drug Benefit Plan.

Authors:  S E Shortt
Journal:  Can Fam Physician       Date:  1995-12       Impact factor: 3.275

3.  The epidemiology of psychotropic drug use in Canada.

Authors:  R Cooperstock
Journal:  Can Fam Physician       Date:  1978-09       Impact factor: 3.275

4.  The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members.

Authors:  R E Johnson; M J Goodman; M C Hornbrook; M B Eldredge
Journal:  Health Serv Res       Date:  1997-04       Impact factor: 3.402

5.  Drug prescription rates before and after enrollment of a Medicaid population in an HMO.

Authors:  D L Rabin; P J Bush; N A Fuller
Journal:  Public Health Rep       Date:  1978 Jan-Feb       Impact factor: 2.792

6.  What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Authors:  Marin C Gemmill; Sarah Thomson; Elias Mossialos
Journal:  Int J Equity Health       Date:  2008-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.